Aptevo Therapeutics (APVO) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.62, -4.71% vs the prior close of $1.70.
- Volume 30.07K shares, 0.3x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
APVO slides 4.7% to $1.62, a 52-week low, 4 down days in a row. Closed at $1.62, -4.71% vs the prior close of $1.70. Day range $1.60–$1.73, opened at $1.73.
APVO daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — APVO slides 4.7% to $1.62, a 52-week low, 4 down days in a row
- Closed at $1.62, -4.71% vs the prior close of $1.70. Day range $1.60–$1.73, opened at $1.73.
- Volume was 30.07K shares, 0.3x its 50-day average of 114.99K — lighter than usual.
- Price is -27.2% vs its 50-day average ($2.23) and -65.8% vs its 200-day average ($4.74).
- 52-week range $1.37–$29.70; today's close sits at 1% of that range, 94.5% below the 52-week high.
- That makes 4 straight losses.
Oct 15, 2026 — APVO dips 1.7% to $1.70, a 52-week low, 3 down days in a row
- Closed at $1.70, -1.73% vs the prior close of $1.73. Day range $1.70–$1.74, opened at $1.73.
- Volume was 10.80K shares, 0.1x its 50-day average of 114.85K — lighter than usual.
- Price is -25.2% vs its 50-day average ($2.27) and -64.4% vs its 200-day average ($4.78).
- 52-week range $1.37–$30.06; today's close sits at 1% of that range, 94.3% below the 52-week high.
- That makes 3 straight losses.
Oct 14, 2026 — APVO ends flat (+0.0%) to $1.73
- Closed at $1.73, +0.00% vs the prior close of $1.73. Day range $1.71–$1.78, opened at $1.73.
- Volume was 21.90K shares, 0.2x its 50-day average of 114.58K — lighter than usual.
- Price is -25.6% vs its 50-day average ($2.32) and -64.1% vs its 200-day average ($4.82).
- 52-week range $1.37–$30.06; today's close sits at 1% of that range, 94.2% below the 52-week high.
- SEC filings that day: 8-K.
Oct 13, 2026 — APVO slides 5.8% to $1.73
- Closed at $1.73, -5.77% vs the prior close of $1.84. Day range $1.70–$1.79, opened at $1.79.
- Volume was 85.70K shares, 0.8x its 50-day average of 113.10K.
- Price is -27.0% vs its 50-day average ($2.37) and -64.5% vs its 200-day average ($4.87).
- 52-week range $1.37–$30.06; today's close sits at 1% of that range, 94.2% below the 52-week high.
Oct 12, 2026 — APVO rises 2.6% to $1.84 on 2.6x normal volume
- Closed at $1.84, +2.57% vs the prior close of $1.79. Day range $1.76–$1.97, opened at $1.79.
- Volume was 282.30K shares, 2.6x its 50-day average of 107.66K — unusually heavy trading.
- Price is -24.0% vs its 50-day average ($2.42) and -62.9% vs its 200-day average ($4.94).
- 52-week range $1.37–$31.14; today's close sits at 2% of that range, 94.1% below the 52-week high.
Oct 9, 2026 — APVO dips 0.6% to $1.79
- Closed at $1.79, -0.56% vs the prior close of $1.80. Day range $1.78–$1.81, opened at $1.79.
- Volume was 6.70K shares, 0.1x its 50-day average of 107.75K — lighter than usual.
- Price is -27.3% vs its 50-day average ($2.46) and -64.4% vs its 200-day average ($5.03).
- 52-week range $1.37–$33.12; today's close sits at 1% of that range, 94.6% below the 52-week high.
Oct 8, 2026 — APVO dips 2.2% to $1.80
- Closed at $1.80, -2.17% vs the prior close of $1.84. Day range $1.77–$1.84, opened at $1.77.
- Volume was 26.70K shares, 0.2x its 50-day average of 107.68K — lighter than usual.
- Price is -28.2% vs its 50-day average ($2.51) and -64.8% vs its 200-day average ($5.12).
- 52-week range $1.37–$33.12; today's close sits at 1% of that range, 94.6% below the 52-week high.
Oct 7, 2026 — APVO rises 2.5% to $1.84
- Closed at $1.84, +2.51% vs the prior close of $1.79. Day range $1.76–$1.85, opened at $1.76.
- Volume was 12.10K shares, 0.1x its 50-day average of 107.60K — lighter than usual.
- Price is -27.9% vs its 50-day average ($2.55) and -64.6% vs its 200-day average ($5.20).
- 52-week range $1.37–$35.64; today's close sits at 1% of that range, 94.8% below the 52-week high.
Oct 6, 2026 — APVO ends flat (-0.3%) to $1.79
- Closed at $1.79, -0.28% vs the prior close of $1.80. Day range $1.79–$1.92, opened at $1.82.
- Volume was 35.40K shares, 0.3x its 50-day average of 107.65K — lighter than usual.
- Price is -30.9% vs its 50-day average ($2.60) and -66.1% vs its 200-day average ($5.29).
- 52-week range $1.37–$35.64; today's close sits at 1% of that range, 95.0% below the 52-week high.
Oct 5, 2026 — APVO rises 2.3% to $1.80
- Closed at $1.80, +2.27% vs the prior close of $1.76. Day range $1.75–$1.85, opened at $1.76.
- Volume was 28.10K shares, 0.3x its 50-day average of 107.14K — lighter than usual.
- Price is -32.0% vs its 50-day average ($2.65) and -66.5% vs its 200-day average ($5.37).
- 52-week range $1.37–$35.64; today's close sits at 1% of that range, 94.9% below the 52-week high.
Oct 2, 2026 — APVO ends flat (+0.0%) to $1.76, 4 down days in a row
- Closed at $1.76, +0.00% vs the prior close of $1.76. Day range $1.76–$1.80, opened at $1.80.
- Volume was 12.60K shares, 0.1x its 50-day average of 107.26K — lighter than usual.
- Price is -34.8% vs its 50-day average ($2.70) and -67.8% vs its 200-day average ($5.46).
- 52-week range $1.37–$35.64; today's close sits at 1% of that range, 95.1% below the 52-week high.
- That makes 4 straight losses.
APVO latest news & SEC filings
Every SEC filing by or about APVO in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 25, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Sep 24, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 23, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Sep 3, 2026 · Form 424B4 — Final prospectus with offering price
Final prospectus with offering price
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Sep 3, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 31, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 31, 2026 · Form CORRESP — Company letter to the SEC
Company letter to the SEC
Aug 27, 2026 · Form UPLOAD — SEC staff letter to the company
SEC staff letter to the company
Aug 21, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 21, 2026 · Form S-1 — Registration statement (S-1)
Registration statement (S-1) — registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Aug 14, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade APVO
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 13, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.21% (largest 5.8%).
- Liquidity: about 41.84K shares (≈$67.79K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.62 vs a range of $1.37–$29.70 (1% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:18 on Dec 30, 2025, 1:20 on May 27, 2025, 1:37 on Dec 4, 2024
- Insider trades (Form 4, last 12 months, recent 25 shown): 4 open-market buys, 0 sales; latest: Grady Iii Grant bought 13,513 shares on Nov 10, 2025.
- Latest filings: 8-K Oct 14, 2026; 8-K Sep 24, 2026; 8-K Sep 23, 2026.
- Share count: 1.80M shares outstanding (Aug 14, 2026), -45.2% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
APVO market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.73 | 1.73 | 1.60 | 1.62 | 30.07K |
| Oct 15, 2026 | 1.73 | 1.74 | 1.70 | 1.70 | 10.80K |
| Oct 14, 2026 | 1.73 | 1.78 | 1.71 | 1.73 | 21.90K |
| Oct 13, 2026 | 1.79 | 1.79 | 1.70 | 1.73 | 85.70K |
| Oct 12, 2026 | 1.79 | 1.97 | 1.76 | 1.84 | 282.30K |
| Oct 9, 2026 | 1.79 | 1.81 | 1.78 | 1.79 | 6.70K |
| Oct 8, 2026 | 1.77 | 1.84 | 1.77 | 1.80 | 26.70K |
| Oct 7, 2026 | 1.76 | 1.85 | 1.76 | 1.84 | 12.10K |
| Oct 6, 2026 | 1.82 | 1.92 | 1.79 | 1.79 | 35.40K |
| Oct 5, 2026 | 1.76 | 1.85 | 1.75 | 1.80 | 28.10K |
| Oct 2, 2026 | 1.80 | 1.80 | 1.76 | 1.76 | 12.60K |
| Oct 1, 2026 | 1.82 | 1.84 | 1.75 | 1.76 | 25.00K |
| Sep 30, 2026 | 1.84 | 1.90 | 1.81 | 1.82 | 24.10K |
| Sep 29, 2026 | 1.90 | 1.91 | 1.84 | 1.86 | 15.00K |
| Sep 28, 2026 | 1.86 | 1.98 | 1.86 | 1.91 | 47.00K |
| Sep 25, 2026 | 1.83 | 1.90 | 1.82 | 1.89 | 25.50K |
| Sep 24, 2026 | 1.88 | 1.90 | 1.81 | 1.83 | 33.00K |
| Sep 23, 2026 | 1.88 | 1.89 | 1.80 | 1.89 | 53.30K |
| Sep 22, 2026 | 1.81 | 1.89 | 1.81 | 1.85 | 39.20K |
| Sep 21, 2026 | 1.84 | 1.89 | 1.80 | 1.81 | 22.40K |
About Aptevo Therapeutics
Aptevo Therapeutics (APVO) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in SEATTLE, WA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1671584.
APVO board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Daniel Abdun-Nabi | Director | Aug 10, 2026 |
| Grady Iii Grant | Director | Aug 10, 2026 |
| Zsolt Harsanyi | Director | Aug 10, 2026 |
| Barbara Lopez Kunz | Director | Aug 10, 2026 |
| Jeffrey G. Lamothe | President and CEO | Aug 10, 2026 |
| John Niederhuber | Director | Aug 10, 2026 |
| Marvin L White | Executive Chair | Aug 10, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Dirk Huebner | SVP, CMO | Aug 10, 2026 |
| Mary Jo Janatpour | SVP, CSO | May 28, 2026 |
| Soyoung Kwon | SVP, GC, BD & Corp Affairs | Aug 10, 2026 |
| Jeffrey G. Lamothe | President and CEO | Aug 10, 2026 |
| Daphne Taylor | SVP, CFO | Aug 10, 2026 |
| Marvin L White | Executive Chair | Aug 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 10, 2025 | Grady Iii Grant | Buy | 13,513 | $1.49 |
| Nov 10, 2025 | Grady Iii Grant | Buy | 13,513 | $1.49 |
| Nov 10, 2025 | Grady Iii Grant | Buy | 13,513 | $1.49 |
| Nov 10, 2025 | Grady Iii Grant | Buy | 13,513 | $1.49 |
APVO financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-25.97M | -87.27 | $-25.59M |
| Dec 31, 2024 | — | $-24.13M | -31,460.23 | $-23.79M |
| Dec 31, 2023 | — | $-17.41M | -2,316.83 | $-11.73M |
| Dec 31, 2022 | $3.11M | $8.03M | 1.57 | $-21.02M |
| Dec 31, 2021 | $12.29M | $-28.46M | -6.07 | $-21.68M |
Latest balance sheet: total assets $14.52M, total liabilities $8.48M, cash $9.80M (as of Jun 30, 2026).
APVO earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $2.94 |
| May 13, 2026 | 8-K Item 2.02 (results) | $4.76 |
| Mar 26, 2026 | 8-K Item 2.02 (results) | $4.51 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $26.46 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $38.70 |
| May 15, 2025 | 8-K Item 2.02 (results) | $118.80 |
| Apr 28, 2025 | 8-K Item 2.02 (results) | $220.32 |
| Feb 14, 2025 | 8-K Item 2.02 (results) | $1,202.40 |
| Nov 7, 2024 | 8-K Item 2.02 (results) | $4,115.88 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 8, 2024 | 8-K Item 2.02 (results) | — |
| Mar 5, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on APVO
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.